Clinical TrialsSearch results
Number of results: 434
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
- Symptomatic uterine leimoyoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase II study of percutaneous osteoplasty for painful malignant bone tumor (JIVROSG-0703)
- Malignant vertebral and pelvic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
- malignant renal tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-04-22
Other
- A phase II study of stent therapy for malignant vena cava syndrome. (JIVROSG-0402)
- Malignant vena cava stenosis.
- Japan Interventional Radiology in Oncology Study Group(JIVROSG)
- 2005-08-07
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22